Volume 141, Issue 6, Pages e8 (December 2011)

Slides:



Advertisements
Similar presentations
Volume 132, Issue 1, Pages (January 2007)
Advertisements

Volume 132, Issue 3, Pages (March 2007)
Volume 124, Issue 5, Pages (May 2003)
Volume 138, Issue 2, Pages e3 (February 2010)
Volume 136, Issue 2, Pages e5 (February 2009)
Volume 133, Issue 6, Pages (December 2007)
Volume 141, Issue 6, Pages e7 (December 2011)
Volume 135, Issue 1, Pages (July 2008)
Volume 139, Issue 2, Pages (August 2010)
Volume 140, Issue 2, Pages e2 (February 2011)
Cell-specific activation profile of extracellular signal-regulated kinase 1/2, Jun N-terminal kinase, and p38 mitogen-activated protein kinases in asthmatic.
Volume 132, Issue 1, Pages (January 2007)
Volume 135, Issue 2, Pages e3 (August 2008)
Volume 136, Issue 3, Pages e2 (March 2009)
Volume 138, Issue 3, Pages e4 (March 2010)
Growth Hormone Inhibits Signal Transducer and Activator of Transcription 3 Activation and Reduces Disease Activity in Murine Colitis  Xiaonan Han, Danuta.
Julie M. Caldwell, PhD, Carine Blanchard, PhD, Margaret H
Volume 131, Issue 4, Pages (October 2006)
Volume 143, Issue 4, Pages e9 (October 2012)
Volume 133, Issue 6, Pages (December 2007)
Aryl Hydrocarbon Receptor Regulates Pancreatic IL-22 Production and Protects Mice From Acute Pancreatitis  Jing Xue, David T.C. Nguyen, Aida Habtezion 
Volume 143, Issue 5, Pages e4 (November 2012)
Therapeutic potential of follistatin for colonic inflammation in mice
Volume 134, Issue 2, Pages (February 2008)
Volume 115, Issue 6, Pages (December 1998)
Cell-specific activation profile of extracellular signal-regulated kinase 1/2, Jun N-terminal kinase, and p38 mitogen-activated protein kinases in asthmatic.
Volume 25, Issue 4, Pages (April 2014)
Volume 134, Issue 1, Pages (January 2008)
Volume 144, Issue 5, Pages e6 (May 2013)
Volume 134, Issue 1, Pages e1 (January 2008)
Volume 137, Issue 3, Pages (September 2009)
Laminin γ2 Mediates Wnt5a-Induced Invasion of Gastric Cancer Cells
Volume 132, Issue 7, Pages (June 2007)
Volume 137, Issue 4, Pages (October 2009)
Volume 141, Issue 4, Pages (October 2011)
Volume 137, Issue 3, Pages (September 2009)
Volume 139, Issue 1, Pages e6 (July 2010)
Volume 142, Issue 3, Pages e2 (March 2012)
Volume 134, Issue 1, Pages (January 2008)
Volume 130, Issue 2, Pages (February 2006)
Volume 134, Issue 4, Pages e2 (April 2008)
Volume 127, Issue 4, Pages (October 2004)
Volume 135, Issue 6, Pages e7 (December 2008)
Volume 127, Issue 1, Pages (July 2004)
Volume 147, Issue 1, Pages (July 2014)
Volume 139, Issue 6, Pages (December 2010)
Volume 138, Issue 2, Pages e3 (February 2010)
Volume 141, Issue 1, Pages e1 (July 2011)
Volume 143, Issue 1, Pages e7 (July 2012)
Volume 143, Issue 1, Pages (July 2012)
Volume 141, Issue 5, Pages e2 (November 2011)
Volume 132, Issue 1, Pages (January 2007)
Volume 134, Issue 2, Pages e3 (February 2008)
Volume 142, Issue 4, Pages e2 (April 2012)
Volume 125, Issue 6, Pages (December 2003)
Volume 135, Issue 3, Pages e3 (September 2008)
Mechanisms of cross hyporesponsiveness to toll-like receptor bacterial ligands in intestinal epithelial cells  Jan-Michel Otte, Elke Cario, Daniel K.
Volume 132, Issue 5, Pages (May 2007)
Volume 119, Issue 4, Pages (October 2000)
Volume 146, Issue 7, Pages e4 (June 2014)
Antigen-Presenting Cell Production of IL-10 Inhibits T-Helper 1 and 17 Cell Responses and Suppresses Colitis in Mice  Bo Liu, Susan L. Tonkonogy, R. Balfour.
Volume 135, Issue 2, Pages e2 (August 2008)
Upregulation of Tenascin-C Expression by IL-13 in Human Dermal Fibroblasts via the Phosphoinositide 3-kinase/Akt and the Protein Kinase C Signaling Pathways 
Ling Zheng, Terrence E. Riehl, William F. Stenson  Gastroenterology 
Volume 139, Issue 4, Pages (October 2010)
Volume 141, Issue 3, Pages (September 2011)
Volume 19, Issue 5, Pages (November 2003)
Volume 132, Issue 2, Pages (February 2007)
Volume 136, Issue 7, Pages (June 2009)
Volume 24, Issue 1, Pages (January 2006)
Presentation transcript:

Volume 141, Issue 6, Pages 2119-2129.e8 (December 2011) Interleukin-13 Damages Intestinal Mucosa via TWEAK and Fn14 in Mice—A Pathway Associated With Ulcerative Colitis  Rei Kawashima, Yuki I. Kawamura, Tomoyuki Oshio, Aoi Son, Motomi Yamazaki, Teruki Hagiwara, Toshihiko Okada, Kyoko Inagaki– Ohara, Ping Wu, Suzanne Szak, Yutaka J. Kawamura, Fumio Konishi, Oki Miyake, Hideaki Yano, Yukio Saito, Linda C. Burkly, Taeko Dohi  Gastroenterology  Volume 141, Issue 6, Pages 2119-2129.e8 (December 2011) DOI: 10.1053/j.gastro.2011.08.040 Copyright © 2011 AGA Institute Terms and Conditions

Figure 1 Gene expression profiling after γ-irradiation. Heat map shows the fold changes in gene expression in the colon of irradiated WT mice as compared with untreated WT mice and irradiated TWEAK KO mice as compared with untreated TWEAK KO mice at 6 and 24 hours after irradiation. Each row corresponds to an individual gene named on the right, with clusters of apoptotic and cell cycle genes as bracketed. Positive (red) and negative (blue) fold changes are as indicated by intensity on the scale bar, with gray indicating no significant change. Data were generated with either 4 or 5 mice per group. Gastroenterology 2011 141, 2119-2129.e8DOI: (10.1053/j.gastro.2011.08.040) Copyright © 2011 AGA Institute Terms and Conditions

Figure 2 IL-13–induced loss of IEC intercellular junctions is dependent on Fn14. (A) Primary culture of jejunum from WT or Fn14 KO mice was performed in the presence or absence (no cytokine) of IL-13 for 4 hours, fixed with formalin, and stained for β-catenin and ZO-1. The shape of a crypt is outlined by a dotted line. (B) WT crypts were dissociated and incubated as previously described. Sections were prepared from collected crypt pellets and stained for β-catenin. (C) Human colonic mucosa was cultured with cytokines for 4 hours and stained with anti–ZO-1 antibody. Images are representative of 3 mice or human cases. Gastroenterology 2011 141, 2119-2129.e8DOI: (10.1053/j.gastro.2011.08.040) Copyright © 2011 AGA Institute Terms and Conditions

Figure 3 IL-13–induced apoptosis of IECs is dependent on Fn14. Primary culture of jejunum from WT or Fn14 KO mice was performed in the presence of cytokines for 4 hours and (A) terminal deoxynucleotidyl transferase–mediated deoxyuridine triphosphate nick-end labeling (TUNEL) staining shown. (B) TUNEL-positive cells were enumerated in ∼10 to 50 crypts from each section prepared from 3 mice, and data are shown as mean ± SD. (C) In addition to IL-13, indicated caspase inhibitors with 0.1% dimethyl sulfoxide were added to the culture as described in Figure 2. Gastroenterology 2011 141, 2119-2129.e8DOI: (10.1053/j.gastro.2011.08.040) Copyright © 2011 AGA Institute Terms and Conditions

Figure 4 IL-13–induced caspase activation is dependent on Fn14. Jejunum tissue was incubated in the presence of indicated cytokines or without (No cytokine) for indicated times, and protein extract was subjected to immunoblotting for caspases or assay for caspase-3 activity. (A) Tissues from WT, Fn14 KO, or TWEAK (TWK) KO mice were incubated with cytokines and probed with anti-activated caspase-3 antibody. Representative photos from experiments repeated 3 times are shown. (B) Activated caspase-3 was detected as in panel A and quantified by densitometry with normalization with β-actin signal, with stimuli and time point (15 or 40 minutes) as indicated. Data from 3 independent experiments are shown as mean ± SD. (C) Caspase-3 activity was measured using WT or Fn14 KO fresh tissues (no culture) or cultured for 40 minutes with IL-13 or without (No cytokine). (D) Caspase-3 activity in WT tissues incubated with (+) or without (−) 0.1 μg/mL of cycloheximide. (E and F) Caspase-3 activity after (E) 40 minutes of culture with IL-13 or (F) 15 minutes of culture with TNF-α. In panels E and F, inhibitors were added to the cultures as indicated: murine TNF receptor-Ig (TNFR-Ig) or the murine control antibody clone P1.17 (Control Ig), and IL-13 receptor α2-Ig (IL-13Ra2-Ig) or its control human IgG (hIg). In panels C to F, data are shown as mean ± SD of 5 cultures as relative activity, fold relative to no cytokine. P values are shown for significant differences between inhibitor and its control reagent or between WT and Fn14 KO tissues. Gastroenterology 2011 141, 2119-2129.e8DOI: (10.1053/j.gastro.2011.08.040) Copyright © 2011 AGA Institute Terms and Conditions

Figure 5 IL-13 induced TNF-α shedding. (A) WT tissues were cultured with IL-13 as in Figure 4 for indicated time with TAPI-2, and TNF-α in the culture supernatant was measured. (B) WT or Fn14 KO tissues were cultured for 80 minutes with or without IL-13 and shed TNF-α was measured. (C) WT tissues were incubated for 120 minutes and caspase-3 activity was measured. Data are shown as mean ± SD of 5 cultures. P values are shown for significant differences between inhibitor and its control or between WT and Fn14 KO tissues. Gastroenterology 2011 141, 2119-2129.e8DOI: (10.1053/j.gastro.2011.08.040) Copyright © 2011 AGA Institute Terms and Conditions

Figure 6 TWEAK/Fn14-mediated spontaneous colitis in IL-10 KO mice. (A) Representative section of the colon stained with H&E. (B) Histologic score, weight of colon and spleen. Each symbol represents an individual animal. (C) Cytokine mRNA levels in total colon tissue shown as relative expression to WT naïve colon. See Supplementary Materials and Methods for details. *Signal for IL-13 was not detected in any IL-10 KO × TWEAK KO and IL-10 KO × Fn14 KO mice. (D) TWEAK and Fn14 mRNA expression in IL-10 KO mice. P values are shown for significant differences between (B and C) IL-10 KO (15 w [weeks old]) and double KO mice (16w) and between (D) naïve and IL-10 KO 15w mice. Gastroenterology 2011 141, 2119-2129.e8DOI: (10.1053/j.gastro.2011.08.040) Copyright © 2011 AGA Institute Terms and Conditions

Figure 7 IL-13, TWEAK, and Fn14 are up-regulated in the inflamed mucosa of patients with UC. RNA extract from surgically resected colon mucosa was subjected to quantitative reverse-transcription polymerase chain reaction for IL-13, TWEAK, and Fn14. (A) Expression of IL-13 and TNF-α. Open bars, sample where transcripts were not detected after 40 cycle of polymerase chain reaction; gray boxes, samples with detectable mRNA; black boxes, samples with more than 2-fold increase when compared with paired uninvolved mucosa. Paired squares indicate uninvolved mucosal sample (U) and involved mucosal sample (I) obtained from the same patient. Percentage of mRNA-positive samples is as indicated at the bottom. The difference in the frequency of IL-13 expression between U and I group was statistically significant (χ2 test). (B) Expression level of TWEAK and Fn14 expressed relative to the average signal value of normal colon is shown. Horizontal lines indicate mean value. (C) Paired samples of uninvolved mucosa and involved mucosa from patients with UC are compared. Paired t test was used for statistical analysis. (D) Samples in panel A separated into IL-13–positive or –negative groups and the levels of TWEAK and Fn14 were compared. Gastroenterology 2011 141, 2119-2129.e8DOI: (10.1053/j.gastro.2011.08.040) Copyright © 2011 AGA Institute Terms and Conditions

Supplementary Figure 1 TWEAK/Fn14 mediates γ-irradiation–induced cell death. (A) Expression of TWEAK, Fn14, and TNF-α in the whole tissue of jejunum and colon after 3-Gy γ-irradiation. Levels of mRNA were determined by quantitative reverse-transcription PCR normalized with GAPDH and demonstrated as fold change from one representative sample of naïve mice. Horizontal bars indicate mean values. (B) Number of microcolonies (regenerative epithelial cells) in the intestine of WT (n = 4) and Fn14 KO (n = 5) mice 6 days after 12-Gy γ-irradiation. Data are shown as mean ± SD. Gastroenterology 2011 141, 2119-2129.e8DOI: (10.1053/j.gastro.2011.08.040) Copyright © 2011 AGA Institute Terms and Conditions

Supplementary Figure 2 TWEAK is a weak inducer of apoptosis of IECs. (A) Small intestines of WT BALB/c mice were taken and cultured in the presence of TNF-α or TWEAK. Protein extract at the indicated time in minutes was examined by Western blotting for caspase-3. (B) Numbers of BrdU-incorporated cells and caspase-3–positive cells in the intestine after intraperitoneal injection of TWEAK-Fc (TWEAK) or control antibody (control). None, no treatment. Numbers in parentheses indicate the number of injections of control or TWEAK: 1 indicates injection on day 0 and tissues obtained on day 1; 3 indicates injection on days 0, 3, and 7 and tissues obtained on day 10; and 5 indicates injection on days 0, 3, 7, 10, and 17 and tissues obtained on day 18. Horizontal bars indicate mean values. Gastroenterology 2011 141, 2119-2129.e8DOI: (10.1053/j.gastro.2011.08.040) Copyright © 2011 AGA Institute Terms and Conditions

Supplementary Figure 3 IL-13–induced caspase activation is dependent on Fn14. Tissues were incubated in the presence of indicated cytokines or without cytokine (Control) for indicated times and protein extract was subjected to immunoblotting for caspases or assay for caspase-3 activity. (A and B) Tissues were prepared from WT mice and incubated with (A) IL-13 for 40 minutes or (B) TNF-α for the indicated time. Active caspase-3 was detected with Western blotting and quantified by densitometry with normalization with β-actin signal. Data from 3 independent experiments are shown as mean ± SD. (C) WT (gray bars) or Fn14 KO (black bars) tissues were incubated with TNF-α for 40 minutes with various inhibitors. Data from 5 independent cultures are shown as mean ± SD (relative to WT tissue with no cytokine). Inhibitors were added to the cultures as indicated to each lane of treatment, namely 5 μg/mL of murine anti-TWEAK antibody P2D10, murine TNF receptor-Ig (TNFR-Ig) or the murine control antibody clone P1.17 (Control Ab), IL-13 receptor α2-Ig (IL-13Ra2-Ig) or its control human IgG (hIg), or none. In A–C, Student t test was performed and P values are shown for significant differences between inhibitor and its control reagent. Gastroenterology 2011 141, 2119-2129.e8DOI: (10.1053/j.gastro.2011.08.040) Copyright © 2011 AGA Institute Terms and Conditions

Supplementary Figure 4 IL-13–induced caspase activation is dependent on Fn14. Small intestinal tissue was incubated in the presence of indicated cytokines or without cytokine (Control) for indicated times (5, 15, or 40 minutes) and protein extract was subjected to immunoblotting for caspases. Tissues were prepared from WT or Fn14 KO mice and incubated with IL-13, IL-4, or TNF-α. Blotted membrane was probed with (A) anti-activated caspase-2, (B) caspase-8, (C) caspase-9, or (D–F) caspase-3. In D–F, tissues were prepared from WT mice and incubated with IL-13 or TNF-α or without (Control). Lanes of treatment indicates culture incubation with media alone (M), IL-13 receptor α2-Ig (Ra2) or its control human IgG (hIg), TNF receptor-Ig (TNFR), anti-TWEAK antibody P2D10 (aTWK), or control antibody clone P1.17 (Ct). Concentrations of antibodies and chimeric proteins are all 5 μg/mL. Gastroenterology 2011 141, 2119-2129.e8DOI: (10.1053/j.gastro.2011.08.040) Copyright © 2011 AGA Institute Terms and Conditions

Supplementary Figure 5 Pathway of intestinal epithelial cell death by exogenous IL-13 and TNF-α. IL-13–induced caspase-3 activation is essentially dependent on endogenous TWEAK/Fn14, and TNF-α shedding induced by the action of TACE. Therefore, in the presence of IL-13, exogenous TNF-α or TWEAK are not necessary to induce apoptosis. Exogenous TNF-α is able to induce apoptosis in the absence of IL-13 or TWEAK/Fn14; however, the IL-13 and TWEAK/Fn14-dependent pathway is also involved in the early phase. Gastroenterology 2011 141, 2119-2129.e8DOI: (10.1053/j.gastro.2011.08.040) Copyright © 2011 AGA Institute Terms and Conditions

Supplementary Figure 6 Induction of Fn14 mRNA by cytokines. Fn14 relative expression values for primary mouse colon tissue cultured with media or indicated cytokine for 6 hours. Each line represents a culture from an individual mouse. Fn14 RNA levels were quantified by real-time PCR and normalized to GAPDH. Fn14 expression is shown as relative expression to the mean value for cultures with media alone. Paired t test was used for statistical analysis. Gastroenterology 2011 141, 2119-2129.e8DOI: (10.1053/j.gastro.2011.08.040) Copyright © 2011 AGA Institute Terms and Conditions